entertainment -WSS

entertainment

author：focus 2025-08-12 08:27:04 - browse：4637

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Amazon expands telehealth clinic nationwide

focus

WSS

Why we need to separate burnout from moral injury in health care

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

‘Oppenheimer’ and the risks of AI in health care

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

#NeedHerScience: shining a light on gender disparities in medicine

Cloning humans is technically possible. It's curious no one has tried

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Paxlovid study fails to answer questions over benefit for broader groups

Jerome Adams on the need for new antivirals for Covid

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

United colonoscopy coverage change 'may cost lives,' doctors say

The strategy behind pharma's lawsuits over drug pricing reform

How one medical school became remarkably diverse

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Micronoma's microbiome cancer diagnostic approach under fire

focus

Wildfire pollution widens asthma inequities on Long Island

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Ask STAT: What do you want to know about ChatGPT in medicine?

5 important ways Henrietta Lacks changed medical science

Micronoma's microbiome cancer diagnostic approach under fire

NIH launches clinical trials and new research office for long Covid

knowledge

explore

focus

leisure time